J Shen, F Senes, X Wen, P Monti, S Lin, C Pinna… - Immunologic …, 2024 - Springer
Background Pomalidomide, a third-generation oral immunomodulatory drug, exhibits
efficacy in patients with relapsed multiple myeloma or those refractory to bortezomib and …